Thu. 9 May 2024, 8:07am ET
Benzinga
Earnings, Earnings Beats, News
Monopar Therapeutics (NASDAQ:MNPR) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.14) by 28.57 percent. This is a 47.37 percent increase over losses of $(0.19) per share from the same period last year.